Subject(s)
Clinical Trials as Topic , Coronavirus Infections/prevention & control , Disclosure , Drug Industry , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Public Opinion , Trust , Viral Vaccines , COVID-19 , COVID-19 Vaccines , China , Clinical Trial Protocols as Topic , Clinical Trials as Topic/ethics , Clinical Trials as Topic/standards , Confidentiality/ethics , Confidentiality/legislation & jurisprudence , Coronavirus Infections/epidemiology , Disclosure/ethics , Disclosure/legislation & jurisprudence , Drug Industry/ethics , Drug Industry/legislation & jurisprudence , Drug Industry/standards , Humans , Pneumonia, Viral/epidemiology , Politics , Russia , Safety , United States , Viral Vaccines/adverse effects , Viral Vaccines/pharmacology , Viral Vaccines/standards , Viral Vaccines/therapeutic useABSTRACT
Teledermatology is now fully incorporated into our clinical practice. However, after reviewing current legislation on the ethical aspects of teledermatology (data confidentiality, quality of care, patient autonomy, and privacy) as well as insurance and professional responsibility, we observed that a specific regulatory framework is still lacking and related legal aspects are still at a preliminary stage of development. Safeguarding confidentiality and patient autonomy and ensuring secure storage and transfer of data are essential aspects of telemedicine. One of the main topics of debate has been the responsibilities of the physicians involved in the process, with the concept of designating a single responsible clinician emerging as a determining factor in the allocation of responsibility in this setting. A specific legal and regulatory framework must be put in place to ensure the safe practice of teledermatology for medical professionals and their patients.
Subject(s)
Confidentiality , Dermatology , Telemedicine , COVID-19/epidemiology , Computer Security/ethics , Computer Security/legislation & jurisprudence , Confidentiality/ethics , Confidentiality/legislation & jurisprudence , Dermatology/ethics , Dermatology/legislation & jurisprudence , Emergencies , European Union , Humans , Informed Consent/legislation & jurisprudence , Insurance, Liability/legislation & jurisprudence , Pandemics , Personal Autonomy , SARS-CoV-2 , Spain , Telemedicine/ethics , Telemedicine/legislation & jurisprudenceABSTRACT
Private Set Intersection Cardinality that enable Multi-party to privately compute the cardinality of the set intersection without disclosing their own information. It is equivalent to a secure, distributed database query and has many practical applications in privacy preserving and data sharing. In this paper, we propose a novel quantum private set intersection cardinality based on Bloom filter, which can resist the quantum attack. It is a completely novel constructive protocol for computing the intersection cardinality by using Bloom filter. The protocol uses single photons, so it only need to do some simple single-photon operations and tests. Thus it is more likely to realize through the present technologies. The validity of the protocol is verified by comparing with other protocols. The protocol implements privacy protection without increasing the computational complexity and communication complexity, which are independent with data scale. Therefore, the protocol has a good prospects in dealing with big data, privacy-protection and information-sharing, such as the patient contact for COVID-19.
Subject(s)
COVID-19 , Computer Security , Confidentiality , Computer Communication Networks , Confidentiality/legislation & jurisprudence , Humans , Information DisseminationSubject(s)
Confidentiality/legislation & jurisprudence , Health Insurance Portability and Accountability Act/history , Confidentiality/history , Genetic Privacy/legislation & jurisprudence , Government Regulation/history , Health Insurance Portability and Accountability Act/legislation & jurisprudence , History, 20th Century , History, 21st Century , Information Dissemination/legislation & jurisprudence , United States , United States Dept. of Health and Human ServicesSubject(s)
COVID-19/ethnology , Emigrants and Immigrants/statistics & numerical data , Ethnicity/statistics & numerical data , Healthcare Disparities , Minority Groups/statistics & numerical data , Patient Advocacy , Bias , COVID-19/mortality , COVID-19/pathology , Confidentiality/legislation & jurisprudence , France/epidemiology , Health Status Disparities , Healthcare Disparities/ethnology , Healthcare Disparities/legislation & jurisprudence , Healthcare Disparities/statistics & numerical data , Humans , Morbidity , Mortality/ethnology , Pandemics , Patient Advocacy/legislation & jurisprudence , Public Health Administration/legislation & jurisprudence , Public Health Administration/standards , Public Health Administration/trends , SARS-CoV-2Subject(s)
Artificial Intelligence/legislation & jurisprudence , COVID-19 , Confidentiality/legislation & jurisprudence , Social Discrimination/legislation & jurisprudence , Health Insurance Portability and Accountability Act , Humans , Machine Learning , Personally Identifiable Information/legislation & jurisprudence , Risk Assessment , SARS-CoV-2 , United StatesABSTRACT
The notion of health information privacy has evolved over time as the healthcare industry has embraced technology. Where once individuals were concerned about the privacy of their conversations and financial information, the digitization of health data has created new challenges for those responsible for ensuring that patient information remains secure and private. Coupled with the lack of updated, overarching legislation, a critical gap exists between advancements in technology, consumer informatics tools and privacy regulations. Almost twenty years after the HIPAA (Health Insurance Portability and Accountability Act) compliance date, the healthcare industry continues to seek solutions to privacy challenges absent formal contemporary law. Since HIPAA, a few attempts have been made to control specific aspects of health information including genetic information and use of technology however none were visionary enough to address issues seen in today's digital data focused healthcare environment. The proliferation of digital health data, trends in data use, increased use of telehealth applications due to COVID-19 pandemic and the consumer's participatory role in healthcare all create new challenges not covered by the existing legal framework. Modern efforts to address this dilemma have emerged in state and international law though the United States healthcare industry continues to operate under a law written two decades ago. As technology continues to advance at a rapid pace along with consumers playing a greater role in the management of their healthcare through digital health the privacy guidance provided by federal law must also shift to reflect the new reality.
Subject(s)
Confidentiality/legislation & jurisprudence , Health Insurance Portability and Accountability Act , Telemedicine/legislation & jurisprudence , COVID-19 , Genome , Humans , SARS-CoV-2 , United StatesSubject(s)
Biomedical Research/legislation & jurisprudence , Confidentiality/legislation & jurisprudence , Coronavirus Infections/epidemiology , European Union , Information Dissemination/legislation & jurisprudence , International Cooperation/legislation & jurisprudence , Pneumonia, Viral/epidemiology , COVID-19 , Confidentiality/standards , Data Anonymization/legislation & jurisprudence , Data Anonymization/standards , Diabetes Mellitus , Humans , National Institutes of Health (U.S.)/legislation & jurisprudence , Neoplasms , Pandemics , Time Factors , United StatesSubject(s)
Censorship, Research , Confidentiality/ethics , Confidentiality/legislation & jurisprudence , Coronavirus Infections , Federal Government , Health Education , Pandemics , Pneumonia, Viral , Social Media , Truth Disclosure/ethics , Administrative Personnel/ethics , COVID-19 , Canada , China , Coronavirus Infections/epidemiology , Coronavirus Infections/therapy , Health Education/ethics , Health Education/standards , Health Policy , Humans , Iran , Pneumonia, Viral/epidemiology , Pneumonia, Viral/therapy , Public Opinion , Quarantine , Reproducibility of Results , Russia , Social Media/ethics , Social Media/standards , Trust , United StatesSubject(s)
Betacoronavirus , Biomedical Research/legislation & jurisprudence , Confidentiality/legislation & jurisprudence , Coronavirus Infections/ethnology , Pneumonia, Viral/ethnology , Racism/legislation & jurisprudence , Biomedical Research/ethics , COVID-19 , Confidentiality/ethics , Coronavirus Infections/mortality , Gynecology/ethics , Gynecology/legislation & jurisprudence , Humans , Obstetrics/ethics , Obstetrics/legislation & jurisprudence , Pandemics , Pneumonia, Viral/mortality , SARS-CoV-2 , United Kingdom/epidemiologySubject(s)
Coronavirus Infections/prevention & control , Dermatology/legislation & jurisprudence , Health Insurance Portability and Accountability Act/legislation & jurisprudence , Infection Control/standards , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Telemedicine/legislation & jurisprudence , Betacoronavirus/pathogenicity , COVID-19 , Computer Security/legislation & jurisprudence , Confidentiality/legislation & jurisprudence , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Coronavirus Infections/virology , Dermatology/economics , Dermatology/standards , Dermatology/trends , Humans , Liability, Legal , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , SARS-CoV-2 , Telemedicine/economics , Telemedicine/standards , Telemedicine/trends , United StatesABSTRACT
Smartphone apps to track SARS-CoV 2 infections need to fulfill certain minimal requirements to guarantee privacy and justify their use under data protection laws.
Subject(s)
Centers for Disease Control and Prevention, U.S./legislation & jurisprudence , Computer Security/legislation & jurisprudence , Confidentiality/legislation & jurisprudence , Contact Tracing/legislation & jurisprudence , Pandemics/legislation & jurisprudence , COVID-19 , Computer Security/standards , Contact Tracing/methods , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , European Union , Humans , Mobile Applications/legislation & jurisprudence , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Practice Guidelines as Topic , Smartphone/legislation & jurisprudence , United StatesSubject(s)
Betacoronavirus/isolation & purification , Clinical Laboratory Techniques/statistics & numerical data , Contact Tracing/legislation & jurisprudence , Coronavirus Infections/diagnosis , Pneumonia, Viral/diagnosis , Privacy/legislation & jurisprudence , COVID-19 , COVID-19 Testing , Confidentiality/legislation & jurisprudence , Contact Tracing/methods , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Health Insurance Portability and Accountability Act/legislation & jurisprudence , Humans , Information Dissemination/legislation & jurisprudence , Mobile Applications , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , SARS-CoV-2 , United States/epidemiologySubject(s)
Betacoronavirus , Communicable Disease Control , Coronavirus Infections/prevention & control , Duty to Warn/legislation & jurisprudence , Pandemics/prevention & control , Physician's Role , Pneumonia, Viral/prevention & control , COVID-19 , Commitment of Mentally Ill/ethics , Confidentiality/legislation & jurisprudence , Coronavirus Infections/transmission , Duty to Warn/ethics , Ethics, Medical , Humans , Mandatory Reporting , Patient Isolation , Pneumonia, Viral/transmission , Psychiatry , SARS-CoV-2 , United StatesSubject(s)
Betacoronavirus , Coronavirus Infections , Delivery of Health Care/methods , Government Regulation , Health Policy/legislation & jurisprudence , Pandemics , Pneumonia, Viral , Telemedicine/legislation & jurisprudence , COVID-19 , Confidentiality/legislation & jurisprudence , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Delivery of Health Care/legislation & jurisprudence , Delivery of Health Care/organization & administration , Humans , Medicare/legislation & jurisprudence , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , SARS-CoV-2 , Telemedicine/methods , United States , Videoconferencing/legislation & jurisprudenceABSTRACT
The novel coronavirus disease 2019 infection poses serious challenges to the healthcare system that are being addressed through the creation of new unique and advanced systems of care with disjointed care processes (eg, telehealth screening, drive-through specimen collection, remote testing, telehealth management). However, our current regulations on the flows of information for clinical care and research are antiquated and often conflict at the state and federal levels. We discuss proposed changes to privacy regulations such as the Health Insurance Portability and Accountability Act designed to let health information seamlessly and frictionlessly flow among the health entities that need to collaborate on treatment of patients and, also, allow it to flow to researchers trying to understand how to limit its impacts.